Sinovac Biotech Ltd (SVA)

[surf1944]

7:05AM Sinovac Biotech receives Jiangsu Province tender award to supply inactivated hepatitis vaccine Healive under expanded immunization program (SVA) 5.70 : Co announced that it has been selected by the Jiangsu Centers for Disease Control and Prevention to supply the Company's inactivated hepatitis A vaccine, Healive, under the Expanded Program of Immunization in 2014 to the pediatric population in Jiangsu Province. The total volume of the tender is up to 1.8 million doses. As one of the two selected suppliers, Sinovac will supply 900,000 doses of Healive to Jiangsu province.